AutoGenomics Receives a Key European Patent for HPV Detection.
AutoGenomics (Carlsbad, CA), a leader in providing automated, molecular testing solutions, has been issued a key European patent for Human papillomavirus human papillomavirus (HPV), any of a family of more than 60 viruses that cause various growths, including plantar warts and genital warts, a sexually transmitted disease. Detectable warts can be or removed, usually by chemicals, freezing, or laser, but often recur. . Patent No.1 499 749 B1, "Human papillomavirus Detection with DNA Microarray," claims to be a method for detecting the presence of HPV HPV human papillomavirus.
human papilloma virus
Human papilloma virus (HPV) using a microarray.
"This patent is the result of our collaboration with Dr. Erik Thunnissen, a prominent clinician and opinion leader in the field of Human papillomavirus," said Mr. Fareed Kureshy, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of AutoGenomics. He further said that "with increasing demands for alternative technologies to meet the evolving need for genotyping we are excited that we can offer an automated solution that can significantly enhance workflow efficiency in the laboratory".
AutoGenomics has developed the first automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease Infectious disease
A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. , cancer and pharmacogenetics Pharmacogenetics Definition
Pharmacogenetics is the study of how the actions of and reactions to drugs vary with the patient's genes.
Description . With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to the era of personalized medicine.